3Liver Failure and Artificial Liver Group, Chinese Society of Infectious Diseases, Chinese Medical Association.肝衰竭诊疗指南[J].中华肝脏病杂志,2006,14(9):643-646. 被引量：829
4Schmilovitz-Weiss H, Ben-Ari Z, Sikuler E, et al. Lamivudine treatment for acute severe hepatitis B: a pilot study. Liver Int, 2004,24:547-551.
5Yu JW, Wang GQ, Li SC. Prediction of the prognosis in patients with acute-on-chronic hepatitis using the MELD scoring system. J Gastroenterol Hepatol,2006,21 : 1519-1524.
6Ashwin N.Ananthakrishnan,Emily L,et al.Uninsured and Medieaid Patients Have Higher Mortality in Acute Liver Failure.Gastroenterology,2008,134:A-799-A-800.
7Chen RN,Ljn CH,Liaw YF.The effect of lamivudine therapy in hepatic decompensation during acute exacerbation of chronic hepatitis B.J Hepatol,2003,38:322-327.
8Schmilovitz-Weiss H,Ben-Ari Z,Sikuler E,et al.Lamivudine treatment for acute severe hepatitis B:a pilot study.Liver Int,2004,24:547-551.
9Tillmann HL,Hadem J,Leifeld L,et al.Safety and efficacy of lamivudine in patients with severe acute or fulminant hepatitis B,a multicenter experience.J Viral Hepat,2006,13:256-263.
10Yu JW,Sun LJ,Zhao YH,et al.Prediction value of model for end-stage liver disease scoring system on prognosis in patients with acute-on-chronic hepatitis B liver failure after plasma exchange and lamivudine treatment.Hepatology,2008,46:1242-1249.
2Liver Failure and Artificial Liver Group, Chinese Society of Infectious Diseases, Chinese Medical Association.肝衰竭诊疗指南[J].中华肝脏病杂志,2006,14(9):643-646. 被引量：829
